VTGN - Vistagen to Present at Psych Congress 2026
Story updates
12:32:04 PM UTC
SquawkNews
Poster presentation highlights positive efficacy signal for fasedienol nasal spray in study participants with very severe social anxiety disorderSOUTH SAN FRANCISCO, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Vistagen NASDAQ:VTGN, a late clinical-stage biopharmaceutical company leveraging nose-to-b…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.